Donald J. Santel - Jan 19, 2023 Form 3 Insider Report for Aerovate Therapeutics, Inc. (AVTE)

Role
Director
Signature
/s/ George A. Eldridge, Attorney-in-Fact
Stock symbol
AVTE
Transactions as of
Jan 19, 2023
Transactions value $
$0
Form type
3
Date filed
1/23/2023, 04:59 PM
Previous filing
Jan 4, 2023
Next filing
Jun 8, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney